1.
ERJ Open Res
; 9(4)2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37529638
RESUMO
Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.